Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Sodium-glucose Cotransporter Type 2 Inhibitors on the Course of Cardiorenal Syndrome in Acute Decompensation of Chronic Heart Failure

NCT04778787 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT04778787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Sodium-glucose Cotransporter Type 2 Inhibitors on the Course of Cardiorenal Syndrome in Acute Decompensation of Chronic Heart Failure
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2021
Completion date
August 1, 2022
Enrollment
370 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure